Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
10/2002
10/10/2002US20020147236 Controlling concentration; side effect reduction
10/10/2002US20020147231 Allosteric adenosine receptor modulators
10/10/2002US20020147195 Piperidine derivatives and anti-platelet agents containing the same
10/10/2002US20020147192 Viricides; antiinflammatory agents; antiallergens; antiarthritic agents
10/10/2002US20020147185 Antihypoxic agents, antiischamic agents, antiarrhythmia agents
10/10/2002US20020147180 Stable amorphous amifostine compositions and methods for the preparation of same
10/10/2002US20020147157 Combination therapy comprising anti-diabetic and anticonvulsant agents
10/10/2002US20020146830 Methods and compositions for delivery of pharmaceutical agents
10/10/2002US20020146678 Determining preferential gene expression pattern in embryonic cells; obtain cells, monitor gene expresion products, incubate with animal growth regulators, monitor gene expresion pattern and differentiation in cells
10/10/2002US20020146466 Solid form compositions containing an extract of a raw material as the active ingredient and process of preparing the same
10/10/2002US20020146416 Human trk receptors and neurotrophic factor inhibitors
10/10/2002US20020146386 In vivo use of water absorbent polymers
10/10/2002DE10116978A1 Kappa-Opiatagonisten für die Behandlung von Erkrankungen der Blase Kappa-opiate agonist for the treatment of diseases of the bladder
10/10/2002DE10115922A1 Cyclisch substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung Cyclic substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use
10/10/2002CA2442827A1 "a method for the preparation of immunologically inert amniotic membranes"
10/10/2002CA2442525A1 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
10/10/2002CA2442484A1 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002CA2442472A1 Therapeutic agent for bladder irritative symptoms associated with benign prostatic hyperplasia
10/10/2002CA2442468A1 Therapeutic agent for bladder hypersensitivity
10/10/2002CA2442463A1 Therapeutic agent for overactive bladder
10/10/2002CA2442452A1 Agent for the treatment of bladder irritative symptoms accompanied by benign prostatic hyperplasia
10/10/2002CA2442437A1 Agent for the treatment of overactive bladder
10/10/2002CA2442064A1 G-protein coupled receptors
10/10/2002CA2442062A1 Secreted proteins
10/10/2002CA2441970A1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
10/10/2002CA2441562A1 Short bioactive peptides and methods for their use
10/10/2002CA2441252A1 Estrogen replacement therapy
10/10/2002CA2440108A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/10/2002CA2439842A1 Gaba-receptor modulators for the treatment of neurodegenerative diseases of the eye
10/10/2002CA2438272A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/09/2002EP1247809A2 Triazine compounds useful as sorbitol dehydrogenase inhibitors
10/09/2002EP1246903A1 Reconstructing organs from decellularized biomaterial scaffold
10/09/2002EP1246843A1 Novel fgf homolog zfgf12
10/09/2002EP1246842A1 Nk cell receptor polynucleotides, polypeptides, and antibodies
10/09/2002EP1246823A1 Pyrimidine and triazine kinase inhibitors
10/09/2002EP1246807A2 Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
10/09/2002EP1246799A1 Substituted pyrrole mannich bases to combat pain and allergic reactions
10/09/2002EP1246793A2 Substituted aminomethyl-phenyl-cyclohexane derivatives
10/09/2002EP1246791A2 Aminomethyl-phenyl-cyclohexanone derivatives
10/09/2002EP1246790A1 Substituted 1 and 2 naphthol mannich bases
10/09/2002EP1246630A1 Compositions and methods for facilitating skin growth and managing skin conditions
10/09/2002EP1246629A1 Methods of using electron active compounds for managing cancer
10/09/2002EP1246623A1 Compounds specific to adenosine a1, a2a, and a3 receptor and uses thereof
10/09/2002EP1246621A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
10/09/2002EP1246538A1 Thickened oil compositions of edible oil
10/09/2002EP1115391B1 Chemotherapy of cancer with acetyldinaline in combination with gemcitabine, capecitabine or cisplatin
10/09/2002EP0853477B1 At1-receptor antagonists for preventing and treating postischemic renal failure and for protecting ischemic kidneys
10/09/2002EP0827505B1 Selected soluble esters of hydroxyl-containing indolocarbazoles
10/09/2002EP0754189B1 Receptor modulating agents and methods relating thereto
10/09/2002EP0732933B1 Use of igf-1 and igfbp-3 in the manufacture of a medicament for treating a renal disorder
10/09/2002CN1373763A Pteridinones and kinase inhibitors
10/09/2002CN1373760A Quinuclidine derivs. as muscarinic M3 receptors ligand and their use
10/09/2002CN1373757A Heterocyclically substd, benzoylguanidine, method for production thereof, use thereof as medicament or means of diagnosis and medicaments contg. same
10/09/2002CN1373751A 'Alpha'-amino-'beta'-sulfonyl hydroxamic acid compounds
10/09/2002CN1373746A Method for reducing 2-dimethylamino-2-phenylpropion-acid ethyl ester content in solutions of 2-dimethylamino-1-phenyl-3-cyclohexene-1-carboxylic acid ethyl ester
10/09/2002CN1373745A 3-amino-2-benzyl-1-phenyl-propane derivs.
10/09/2002CN1373662A 3(5)-amino-pyrazole derivs., process for their preparation and their use as antitumor agents
10/09/2002CN1373660A Method for treating chronic pain using MEK inhibitors
10/09/2002CN1373126A Crystallization formed N-(4-trifluoromethylphenyl)-5-methyl isooxazo-4-carboxamide
10/09/2002CN1372945A Magnetotherapeutic medicinal pad and its preparing process
10/09/2002CN1372923A Release controlled Tuoteluoding Tartrate and its preparing process
10/09/2002CN1092049C Composition for treating late allergic reactions and inflammation diseases, and use thereof
10/08/2002US6462076 Beta-amino acid nitrile derivatives as cathepsin K inhibitors
10/08/2002US6462057 Compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
10/08/2002US6462047 Containing 5- or 6-membered oxygen, nitrogen and/or sulfur heteroaryl group; angina, hypertension, respiratory distress, congestive heart failure, renal failure, atherosclerosis, inflammatory diseases, strokes, bronchitis, asthma
10/08/2002US6462038 Such as 1,2,3,6-tetrahydro-1-methyl-9-(trifluoromethyl)-7h-(1,4)oxazino(3,2 -g)quinolin-7-one; nonsteroidal, high affinity and specificity antagonists and agonists or partial agonists, i.e. partial and/or tissue specific activators
10/08/2002US6462022 Lisinopril compositions having large-particle DCPD
10/08/2002US6461625 Nanoemulsion based on alkoxylated alkenyl succinates or alkoxylated alkenyl succinates of glucose and its uses in the cosmetics, dermatological, opthalmological and/or pharmaceutical fields
10/08/2002CA2252982C Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
10/08/2002CA2196769C Benzimidazole derivatives having dopaminergic activity
10/03/2002WO2002077642A1 Mthod of screening drug for preventing/treating proliferative glomerular nephritis
10/03/2002WO2002077263A2 Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon
10/03/2002WO2002077226A1 Prostaglandin ep1 receptor
10/03/2002WO2002077217A2 Human dual specificity protein phosphatase 7-like protein
10/03/2002WO2002077028A1 Polypeptides and nucleic acids for bolekine
10/03/2002WO2002077017A2 Medical uses of intercellular communication facilitating compounds
10/03/2002WO2002077003A1 Process for obtaining lignan, pharmaceutical compositions and uses thereof
10/03/2002WO2002076995A2 2-amino-propanol derivatives
10/03/2002WO2002076989A1 Protein phosphate inhibitors
10/03/2002WO2002076986A1 Pyrazolopyrimidines as therapeutic agents
10/03/2002WO2002076979A1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
10/03/2002WO2002076977A2 Rho-kinase inhibitors
10/03/2002WO2002076976A2 Rho-kinase inhibitors
10/03/2002WO2002076964A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
10/03/2002WO2002076948A1 Novel piperidine derivatives as modulators of chemokine receptors
10/03/2002WO2002076946A2 Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain.
10/03/2002WO2002076926A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/03/2002WO2002076497A2 Method and composition
10/03/2002WO2002076478A1 Bioactivity of methyl palmitate obtained from a mangrove plant salvadora persica l
10/03/2002WO2002076468A1 Tumor therapy with alphavirus-based and high affinity laminin receptor-targeted vectors
10/03/2002WO2002076450A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/03/2002WO2002076443A1 Use of breakers of advanced glycation endproducts for treating deleterious effects of aging and debilitating diseases
10/03/2002WO2002076404A2 Fatty alcohol drug conjugates
10/03/2002WO2002076402A2 Fatty amine drug conjugates
10/03/2002WO2002076390A2 Methods for treating stress disorders using glucocorticoid receptor-specific antagonists
10/03/2002WO2002076196A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof
10/03/2002WO2002066497A3 Tetrapeptide regulating prostate functions and its compositions and methods
10/03/2002WO2002062794A3 Compounds
10/03/2002WO2002046226A3 Trefoil factor 2 (tff2) peptides with moiety attached to asn15
10/03/2002WO2002018407A3 Antisense oligonucleotides against vanilloid receptor 1
1 ... 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 ... 562